Nurse Practitioner, Complex Malignant Hematology

Up to five (5) years of relevant experience; including three (3) years of experience working in the malignant hematology preferred

Experience in nursing research methodology an asset

Evidence of professional malpractice insurance

Membership in the Canadian Association of Nurses in Oncology (CANO) and other organizations relevant to the role preferred

Knowledge of data management programs an asset

Effective interpersonal and customer services skills

Why join UHN?

As a Nurse Practitioner in the Brain Metastases and Gamma Knife program, you will have the opportunity to make a significant impact on the lives of patients and families while working in a world-class cancer centre. UHN provides a collaborative, innovative environment that supports professional growth and continuous learning.

Apply now to join our mission of transforming lives and communities through excellence in care, discovery, and learning.

In addition to working alongside some of the most talented and inspiring healthcare professionals in the world, UHN offers a wide range of benefits, programs and perks. It is the comprehensiveness of these offerings that makes it a differentiating factor, allowing you to find value where it matters most to you, now and throughout your career at UHN.

Competitive offer packages

Government organization and a member of the Healthcare of Ontario Pension Plan (HOOPP

Number of vacancies:

Oncology Nursing Leadership, Collaborative Academic Practice

As a member of the Complex Malignant Hematology Team, the Nurse Practitioner (NP) functions in an expanded role demonstrating a high level of autonomy and expert skill to manage the care required for patients referred to the Princess Margaret Cancer Centre.

The NP will primarily care for patients admitted at PM and support patients within the CMH programs who may be admitted at other UHN sites.

Leukemia (Outpatient):

Rotating through Malignant Hematology Day Unit, Leukemia Rapid Assessment Clinic (RAC) and the Bone Marrow Biopsy and Aspirate clinic (BMBA) in predominantly NP led clinics and treatment areas.

UHN is Canada’s #1 hospital and the world’s #1 publicly funded hospital. With 10 sites and more than 44,000 TeamUHN members, UHN consists of Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre, Toronto Rehabilitation Institute, The Michener Institute of Education and West Park Healthcare Centre. As Canada's top research hospital, the scope of biomedical research and complexity of cases at UHN have made it a national and international source for discovery, education and patient care. UHN has the largest hospital-based research program in Canada, with major research in neurosciences, cardiology, transplantation, oncology, surgical innovation, infectious diseases, genomic medicine and rehabilitation medicine. UHN is a research hospital affiliated with the University of Toronto.

UHN’s vision is to build A Healthier World and it’s only because of the talented and dedicated people who work here that we are continually bringing that vision closer to reality.

www.uhn.ca